Advanced Medical Solutions Group (LON:AMS) Hits New 12-Month High – Should You Buy?

Advanced Medical Solutions Group plc (LON:AMSGet Free Report) shares reached a new 52-week high during trading on Friday . The company traded as high as GBX 248.50 and last traded at GBX 237, with a volume of 1976331 shares changing hands. The stock had previously closed at GBX 207.50.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on AMS shares. Peel Hunt reaffirmed a “buy” rating and issued a GBX 246 price target on shares of Advanced Medical Solutions Group in a report on Wednesday, September 17th. Berenberg Bank restated a “buy” rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of GBX 273.67.

Check Out Our Latest Research Report on Advanced Medical Solutions Group

Advanced Medical Solutions Group Trading Up 13.8%

The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. The firm has a market cap of £510.44 million, a PE ratio of 56.60, a PEG ratio of 5.00 and a beta of 0.74. The stock’s 50 day simple moving average is GBX 217.66 and its 200 day simple moving average is GBX 210.17.

Advanced Medical Solutions Group (LON:AMSGet Free Report) last posted its quarterly earnings data on Wednesday, September 17th. The company reported GBX 5.77 earnings per share for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. On average, sell-side analysts forecast that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current fiscal year.

Insider Activity

In other Advanced Medical Solutions Group news, insider A Christopher (Chris) Meredith sold 50,510 shares of Advanced Medical Solutions Group stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of GBX 218, for a total transaction of £110,111.80. Also, insider Eddie Johnson sold 18,726 shares of the company’s stock in a transaction dated Monday, October 6th. The stock was sold at an average price of GBX 220, for a total value of £41,197.20. Insiders own 4.12% of the company’s stock.

Advanced Medical Solutions Group Company Profile

(Get Free Report)

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.

Recommended Stories

Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.